4
Changes in Ownership
Avalo Therapeutics, Inc. Filed Acc 0001578563-19-000020
Chief Scientific Officer bought 4,549 shares at $2.85 ($12,953)
From the SEC's structured data for this filing
Trades in this filing
Calias Pericles · Chief Scientific Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2019-06-10 | Purchase : show line 1 in the form | +4,549 | $2.85 | $12,953 | 49,549 | D |
| Open-market purchases · 4,549 sh · avg $2.85 · $12,953 | ||||||
Loading xslF345X03/primary_doc.xml…